BIVALIRUDINE ACCORD 250 mg, powder for solution for dilution for solution for injection/for infusion 10 bottles of 10 ml
Active ingredients: Bivalirudin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for injection or infusion10 bottles of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIVALIRUDINE ACCORD 250 mg, poudre pour solution à diluer pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Feb 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61234861CIP75504868CIP133400955048688Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BIVALIRUDINEpoudre | 250 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.